Richard Wagner
Vorstandsvorsitzender bei Bonito Biosciences
Vermögen: - $ am 31.05.2024
Aktive Positionen von Richard Wagner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Bonito Biosciences | Vorstandsvorsitzender | 01.06.2022 | - |
| Gründer | 01.06.2022 | - |
Karriereverlauf von Richard Wagner
Ehemalige bekannte Positionen von Richard Wagner
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ETERNA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 06.07.2023 | 08.08.2023 |
| Independent Dir/Board Member | 06.07.2023 | 08.08.2023 | |
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Vorstandsvorsitzender | 01.01.2009 | 03.06.2020 |
| Gründer | 01.01.2009 | 03.06.2020 | |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Vorstandsvorsitzender | 01.05.2019 | - |
| Gründer | 01.05.2019 | - | |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Richard Wagner
| Brown University | Doctorate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Executive Officer | 3 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
| Bonito Biosciences | |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
- Börse
- Insiders
- Richard Wagner
- Erfahrung
